Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies

被引：6

作者：

Fluemann, Ruth ^{[1
,2
,3
,4
,5
,6
]}

Hansen, Julia ^{[6
]}

Pelzer, Benedikt W. ^{[1
,2
,5
,7
]}

Nieper, Pascal ^{[1
,2
,3
,4
,5
]}

Lohmann, Tim ^{[1
,2
,3
,4
,5
]}

Kisis, Ilmars ^{[1
,2
,3
,4
,5
,8
]}

Riet, Tobias ^{[1
,2
,3
]}

Kohlhas, Viktoria ^{[1
,2
,3
,4
]}

Phuong-Hien Nguyen ^{[1
,2
,3
,4
]}

Peifer, Martin ^{[2
,3
,8
]}

Abedpour, Nima ^{[2
,3
,8
]}

Bosco, Graziella ^{[2
,8
]}

Thomas, Roman K. ^{[2
,8
]}

Kochanek, Moritz ^{[1
,2
]}

Knufer, Jacqueline ^{[1
,2
]}

Jonigkeit, Lorenz ^{[1
,2
]}

Beleggia, Filippo ^{[1
,2
,3
,4
,5
,8
]}

Holzem, Alessandra ^{[1
,2
,3
,4
,5
]}

Buttner, Reinhard ^{[2
,9
]}

Lohneis, Philipp ^{[2
,9
]}

Meinel, Jorn ^{[2
,9
]}

Ortmann, Monika ^{[2
,9
]}

Persigehl, Thorsten ^{[10
,11
]}

Hallek, Michael ^{[1
,2
,3
,4
,5
]}

Calado, Dinis Pedro ^{[12
]}

Chmielewski, Markus ^{[1
,2
,3
]}

Klein, Sebastian ^{[13
]}

Goethert, Joachim R. ^{[13
]}

Chapuy, Bjoern ^{[14
]}

Zevnik, Branko ^{[3
]}

Wunderlich, F. Thomas ^{[15
]}

von Tresckow, Bastian ^{[13
]}

Jachimowicz, Ron D. ^{[1
,2
,3
,4
,5
,6
]}

Melnick, Ari M. ^{[7
]}

Reinhardt, Hans Christian ^{[13
]}

Knittel, Gero ^{[13
]}

机构：

[1] Univ Cologne, Dept Internal Med 1, Ctr Integrated Oncol, Aachen Bonn Cologne Duesseldorf,Fac Med, Cologne, Germany

[2] Univ Hosp Cologne, Cologne, Germany

[3] Univ Cologne, Ctr Mol Med, Cologne, Germany

[4] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany

[5] Univ Cologne, Fac Med, Mildred Scheel Sch Oncol, Aachen Bonn Cologne Dusseldorf, Cologne, Germany

[6] Max Planck Inst Biol Ageing, Cologne, Germany

[7] Cornell Univ, Dept Med, Div Hematol Oncol, Weill Cornell Med, New York, NY USA

[8] Univ Cologne, Fac Med, Dept Translat Genom, Cologne, Germany

[9] Univ Cologne, Fac Med, Inst Pathol, Cologne, Germany

[10] Univ Cologne, Fac Med, Dept Radiol & Intervent Radiol, Cologne, Germany

[11] Univ Cologne, Univ Hosp Cologne, Cologne, Germany

[12] Francis Crick Inst, London, England

[13] Univ Duisburg Essen, Univ Hosp Essen,German Canc Consortium DKTK Partn, West German Canc Ctr,Dept Hematol & Stem Cell Tra, Ctr Mol Biotechnol,German Canc Consortium DKTK Pa, Essen, Germany

[14] Charite Univ Med Ctr Berlin, Dept Hematol Oncol & Tumorimmunol, Campus Benjamin Franklin, Berlin, Germany

[15] Max Planck Inst Metab Res, Dept Neuronal Control Metab, Cologne, Germany

来源：

BLOOD CANCER DISCOVERY | 2023年 / 4卷 / 01期

关键词：

B-CELL LYMPHOMA; PLASMABLASTIC LYMPHOMA; CLINICAL-PRACTICE; GERMINAL-CENTERS; ETS PROTEIN; T-CELLS; SPI-B; RECEPTOR; TRANSPLANTATION; RITUXIMAB;

D O I：

10.1158/2643-3230.BCD-22-0007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Genomic profi ling revealed the identity of at least 5 subtypes of diffuse large B-cell lymphoma (DLBCL), including the MCD/C5 cluster characterized by aberrations in MYD88, BCL2, PRDM1, and/or SPIB. We generated mouse models harboring B cell-specifi c Prdm1 or Spib aberrations on the background of oncogenic Myd88 and Bcl2 lesions. We deployed whole-exome sequencing, transcriptome, fl ow-cytometry, and mass cytometry analyses to demonstrate that Prdm1- or Spib-altered lymphomas display molecular features consistent with prememory B cells and light-zone B cells, whereas lymphomas lacking these alterations were enriched for late light-zone and plasmablast-associated gene sets. Consistent with the phenotypic evidence for increased B cell receptor signaling activity in Prdm1-altered lymphomas, we demonstrate that combined BTK/BCL2 inhibition displays therapeutic activity in mice and in fi ve of six relapsed/refractory DLBCL patients. Moreover, Prdm1-altered lymphomas were immunogenic upon transplantation into immuno-competent hosts, displayed an actionable PD-L1 surface expression, and were sensitive to antimurine-CD19-CAR-T cell therapy, in vivo. SIGNIFICANCE: Relapsed/refractory DLBCL remains a major medical challenge, and most of these patients succumb to their disease. Here, we generated mouse models, faithfully recapitulating the biol-ogy of MYD88-driven human DLBCL. These models revealed robust preclinical activity of combined BTK/BCL2 inhibition. We confi rmed activity of this regimen in pretreated non-GCB-DLBCL patients.

引用

页码：78 / 97

页数：20

共 59 条

[1] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].

Alizadeh, AA ;

Eisen, MB ;

Davis, RE ;

Ma, C ;

Lossos, IS ;

Rosenwald, A ;

Boldrick, JG ;

Sabet, H ;

Tran, T ;

Yu, X ;

Powell, JI ;

Yang, LM ;

Marti, GE ;

Moore, T ;

Hudson, J ;

Lu, LS ;

Lewis, DB ;

Tibshirani, R ;

Sherlock, G ;

Chan, WC ;

Greiner, TC ;

Weisenburger, DD ;

Armitage, JO ;

Warnke, R ;

Levy, R ;

Wilson, W ;

Grever, MR ;

Byrd, JC ;

Botstein, D ;

Brown, PO ;

Staudt, LM .

NATURE, 2000, 403 (6769) :503-511

[2] Germinal centres and B cell lymphomagenesis [J].

Basso, Katia ;

Dalla-Favera, Riccardo .

NATURE REVIEWS IMMUNOLOGY, 2015, 15 (03) :172-184

[3] Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes [J].

Chapuy, Bjoern ;

Stewart, Chip ;

Dunford, Andrew J. ;

Kim, Jaegil ;

Kamburov, Atanas ;

Redd, Robert A. ;

Lawrence, Mike S. ;

Roemer, Margaretha G. M. ;

Li, Amy J. ;

Ziepert, Marita ;

Staiger, Annette M. ;

Wala, Jeremiah A. ;

Ducar, Matthew D. ;

Leshchiner, Ignaty ;

Rheinbay, Ester ;

Taylor-Weiner, Amaro ;

Coughlin, Caroline A. ;

Hess, Julian M. ;

Pedamallu, Chandra S. ;

Livitz, Dimitri ;

Rosebrock, Daniel ;

Rosenberg, Mara ;

Tracy, Adam A. ;

Horn, Heike ;

van Hummelen, Paul ;

Feldman, Andrew L. ;

Link, Brian K. ;

Novak, Anne J. ;

Cerhan, James R. ;

Habermann, Thomas M. ;

Siebert, Reiner ;

Rosenwald, Andreas ;

Thorner, Aaron R. ;

Meyerson, Matthew L. ;

Golub, Todd R. ;

Beroukhim, Rameen ;

Wulf, Gerald G. ;

Ott, German ;

Rodig, Scott J. ;

Monti, Stefano ;

Neuberg, Donna S. ;

Loeffler, Markus ;

Pfreundschuh, Michael ;

Truemper, Lorenz ;

Getz, Gad ;

Shipp, Margaret A. .

NATURE MEDICINE, 2018, 24 (05) :679-+

[4] Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification [J].

Cheson, Bruce D. ;

Fisher, Richard I. ;

Barrington, Sally F. ;

Cavalli, Franco ;

Schwartz, Lawrence H. ;

Zucca, Emanuele ;

Lister, T. Andrew .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3059-+

[5] Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma [J].

Chow, Victor A. ;

Shadman, Mazyar ;

Gopal, Ajay K. .

BLOOD, 2018, 132 (08) :777-781

[6] Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study [J].

Crump, Michael ;

Neelapu, Sattva S. ;

Farooq, Umar ;

Van den Neste, Eric ;

Kuruvilla, John ;

Westin, Jason ;

Link, Brian K. ;

Hay, Annette ;

Cerhan, James R. ;

Zhu, Liting ;

Boussetta, Sami ;

Feng, Lei ;

Maurer, Matthew J. ;

Navale, Lynn ;

Wiezorek, Jeff ;

Go, William Y. ;

Gisselbrecht, Christian .

BLOOD, 2017, 130 (16) :1800-1808

[7] Copy-number analysis and inference of subclonal populations in cancer genomes using Sclust [J].

Cun, Yupeng ;

Yang, Tsun-Po ;

Achter, Viktor ;

Lang, Ulrich ;

Peifer, Martin .

NATURE PROTOCOLS, 2018, 13 (06) :1488-1501

[8] Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma [J].

Davids, Matthew S. ;

Roberts, Andrew W. ;

Seymour, John F. ;

Pagel, John M. ;

Kahl, Brad S. ;

Wierda, William G. ;

Puvvada, Soham ;

Kipps, Thomas J. ;

Anderson, Mary Ann ;

Salem, Ahmed Hamed ;

Dunbar, Martin ;

Zhu, Ming ;

Peale, Franklin ;

Ross, Jeremy A. ;

Gressick, Lori ;

Desai, Monali ;

Kim, Su Young ;

Verdugo, Maria ;

Humerickhouse, Rod A. ;

Gordon, Gary B. ;

Gerecitano, John F. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08) :826-833

[9] Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation [J].

Epperla, Narendranath ;

Badar, Talha ;

Szabo, Aniko ;

Vaughn, John ;

Borson, Steve ;

Saini, Neeraj Y. ;

Patel, Romil D. ;

Shah, Nirav N. ;

Hamadani, Mehdi ;

Ahmed, Sairah ;

Cashen, Amanda F. ;

Fenske, Timothy S. .

BLOOD ADVANCES, 2019, 3 (11) :1661-1669

[10] An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities [J].

Fluemann, Ruth ;

Rehkaemper, Tim ;

Nieper, Pascal ;

Pfeiffer, Pauline ;

Holzem, Alessandra ;

Klein, Sebastian ;

Bhatia, Sanil ;

Kochanek, Moritz ;

Kisis, Ilmars ;

Pelzer, Benedikt W. ;

Ahlert, Heinz ;

Hauer, Julia ;

Guerreiro, Alexandra da Palma ;

Ryan, Jeremy A. ;

Reimann, Maurice ;

Riabinska, Arina ;

Wiederstein, Janica ;

Krueger, Marcus ;

Deckert, Martina ;

Altmueller, Janine ;

Klatt, Andreas R. ;

Frenzel, Lukas P. ;

Pasqualucci, Laura ;

Beguelin, Wendy ;

Melnick, Ari M. ;

Sander, Sandrine ;

Montesinos-Rongen, Manuel ;

Brunn, Anna ;

Lohneis, Philipp ;

Buettner, Reinhard ;

Kashkar, Hamid ;

Borkhardt, Arndt ;

Letai, Anthony ;

Persigehl, Thorsten ;

Peifer, Martin ;

Schmitt, Clemens A. ;

Reinhardt, Hans Christian ;

Knittel, Gero .

BLOOD CANCER DISCOVERY, 2021, 2 (01) :70-91

← 1 2 3 4 5 6 →